Deanna N Parke

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Molecular cancer therapeutics

Molecular cancer research : MCR

Mississippi State University (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Mississippi State University

United States

MSC

Publications

Shanshan Deng, Raisa I Krutilina, Kelli L Hartman, Hao Chen, Deanna N Parke, Rui Wang, Sasha H Shafikhani, Dejian Ma, Pradeep B Lukka, Bernd Meibohm, Tiffany N Seagroves, Duane D Miller, Wei Li
Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer. Molecular cancer therapeutics 21 (7) (2022)
Amy R Dwyer, Carlos Perez Kerkvliet, Raisa I Krutilina, Hilaire C Playa, Deanna N Parke, Warner A Thomas, Branden A Smeester, Branden S Moriarity, Tiffany N Seagroves, Carol A Lange
Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling. Molecular cancer research : MCR 19 (2) (2020)
Shanshan Deng, Raisa I Krutilina, Qinghui Wang, Zongtao Lin, Deanna N Parke, Hilaire C Playa, Hao Chen, Duane D Miller, Tiffany N Seagroves, Wei Li
An Orally Available Tubulin Inhibitor, VERU-111, Suppresses Triple-Negative Breast Cancer Tumor Growth and Metastasis and Bypasses Taxane Resistance. Molecular cancer therapeutics 19 (2) (2019)